Innovation Pharmaceuticals Inc (IPIX)

[noretreat]

Bunny...the results could indeed still be blinded. The company knows the percent of responders combined overall. If that rate of response is below or near the "normal" response rate for placebo, there is really no need to rush to unblind the data, particularly when funds have dried up.

Another biotech I'm in recently announced, ahead of unblinding, that their combined results showed a lot of promise and were well above expected placebo response. The stock has gone up over 40% so far. Topline is coming soon. When it finally is announced, there may be a selloff.